The somatic mutation JAK2-V617F is the most frequently observed driver mutation in BCR/ABL-negative MPNs, such as polycythemia vera (PV) and primary myelofibrosis (PMF) [4]. Here, ABL1 is linked to acquired polycythemia vera.